Previous 10 | Next 10 |
Products will be listed on PAGB's OTC Directory online, a go-to resource for healthcare professionals CHICAGO, IL / ACCESSWIRE / July 12, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM) , an international pharmaceutical company with a proprietary line of nutraceuti...
CHICAGO, IL / ACCESSWIRE / July 8, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical dev...
Cosmos Holdings ( NASDAQ: COSM ) said Wednesday it will acquire LIFE NLB's product portfolio related to bone health targeting human gastrointestinal microbiome, including Bone-Vio and Bone-X. The Bone-Vio product is a combination of calcium citrate, Vitamin D and prebiotic...
Acquisition will include all launched and under development bone health products CHICAGO, IL / ACCESSWIRE / July 6, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor o...
CHICAGO, IL / ACCESSWIRE / June 30, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical de...
Gainers: Heart Core Enterprises (HTCR) +151%. MINISO Group Holding (MNSO) +33%. Imperial Petroleum (IMPP) +33%. Cyren (CYRN) +33%. One Connect Financial Technology (OCFT) +27%. SQL Technologies (SKYX) +27%. Rekor Systems (REKR) +27%. Rubius Therapeutics (RUBY) +24%. Bluejay Diagnostics (BJDX)...
Gainers: DBV Technologies (DBVT) +21%. Rubius Therapeutics (RUBY) +20%. Annovis Bio (ANVS) +17%. LumiraDx (LMDX) +16%. CTI BioPharma (CTIC) +15%. Losers: Rigel Pharmaceuticals (RIGL) -48%. Cosmos (COSM) -13%. Accelerate Diagnostics (AXDX) ...
First commercial launch of the Company's nutraceutical products in the U.S. follows successful launches on Amazon in other key markets CHICAGO, IL / ACCESSWIRE / June 2 , 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with...
Reports Positive Net Income of $0.2 Million and $1.2 Million of EBITDA for the First Quarter of 2022 CHICAGO, IL / ACCESSWIRE / May 18, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceutica...
First commercial launch of nutraceutical products in North American Market CHICAGO, IL / ACCESSWIRE / May 5, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of brand...
News, Short Squeeze, Breakout and More Instantly...
CHICAGO, IL / ACCESSWIRE / July 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and di...
CHICAGO, IL / ACCESSWIRE / July 10, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and di...
CHICAGO, IL / ACCESSWIRE / July 9, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and dis...